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Abstract 
Background: Evidence from case–control studies suggest that dietary fiber may be inversely 
related to breast cancer risk, but it is unclear if this is supported by prospective data. We 
conducted a systematic review and meta-analysis of 
the evidence from prospective studies. 
Methods: PubMed was searched for prospective studies of fiber intake and breast cancer risk 
until 31st August 2011. Random effects models were used to estimate summary relative risks 
(RRs). 
Results: Sixteen prospective studies were included. The summary RR for the highest versus 
the lowest intake was 0.93 [95% confidence interval (CI) 0.89–0.98, I2 = 0%] for dietary 
fiber, 0.95 (95% CI 0.86–1.06, I2 = 4%) for fruit fiber, 0.99 (95% CI 0.92–1.07, I2 = 1%) for 
vegetable fiber, 0.96 (95% CI 0.90–1.02, I2 = 5%) for cereal fiber, 0.91 (95% CI 
0.84–0.99, I2 = 7%) for soluble fiber and 0.95 (95% CI 0.89–1.02, I2 = 0%) for insoluble 
fiber. The summary RR per 10 g/day of dietary fiber was 0.95 (95% CI 0.91–0.98, I2 = 0%, 
Pheterogeneity = 0.82). In stratified analyses, the inverse association was only observed among 
studies with a large range (≥13 g/day) or high level of intake (≥25 g/day). 
Conclusion: In this meta-analysis of prospective studies, there was an inverse association 
between dietary fiber intake and breast cancer risk. 
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Introduction 
 
Breast cancer is the most common cause of cancer in women, with 1.4 million new cases 
diagnosed worldwide in 2008, accounting for ~23% of all cancer cases and 14% of all cancer 
deaths among women [1]. Breast cancer rates increase with industrialization and urbanization 
and are higher in high-income countries than in low- and middle-income countries, however, 
rates are rapidly increasing in low- and middle-income countries [2, 3]. The large 
international variation in breast cancer rates [1], coupled with the rapidly increasing rates 
observed in secular trend studies [2, 3] and migration studies [4, 5], suggest the importance of 
modifiable risk factors in breast cancer etiology.  
 
Dietary factors have long been suspected to be implicated in the development of breast 
cancer, however, in spite of the large literature existing, few convincing dietary risk factors 
have been identified (e.g. alcohol intake) [6]. Dietary fiber has been hypothesized to reduce 
breast cancer risk based on observations that vegetarian women have increased fecal 
estrogens and lower blood concentrations of estrogen compared with omnivorous women [7, 
8]. It has been shown that dietary fiber may inhibit intestinal reabsorption of estrogens and 
may increase fecal excretion of estrogens [9]. However, epidemiological studies of dietary 
fiber intake and breast cancer risk have reported inconsistent findings. An early meta-analysis 
of 12 case–control studies reported an inverse association [summary odds ratio (OR) = 0.85] 
between dietary fiber intake and breast cancer risk [10]. In contrast, most [11–27] but not all 
[28] prospective studies have reported no statistically significant association between fiber 
intake and breast cancer risk. It is unclear whether the seemingly discrepant results by study 
design are explained by differences in the range or level of fiber intake, low statistical power 
in individual studies, population characteristics or measurement error in prospective studies 
or by selection and recall biases in case–control studies. It is also not clear if specific types of 
fiber are associated with breast cancer risk. The World Cancer Research Fund/American 
Institute for Cancer Research (WCRF/AICR) report from 2007 ‘‘Food, Nutrition, Physical 
Activity and the Prevention of Cancer: A Global Perspective’’ stated that the evidence for an 
association between fiber intake and breast cancer risk was either too limited or inconsistent 
for a conclusion [6]. Since that report was released, eight prospective studies (nine 
publications) have been published on dietary fiber intake and breast cancer risk [20–28]. 
Here, we systematically review the evidence with an aim of clarifying the dose–response 
relationship between dietary fiber intake and breast cancer risk, to explore potential sources 
of heterogeneity across study results and whether the results differ by the range or level of 
fiber intake or by type of fiber.  
 
 
Methods 
 
Search strategy 
The literature search and data extraction up to December 2005 was conducted by several 
reviewers at Istituto Nazionale Tumori, Milan. Initially, several databases were searched 
including PubMed, Embase, CAB Abstracts, ISI Web of Science, BIOSIS, Latin American 
and Caribbean Center on Health Sciences Information, Cochrane library, Cumulative Index 
to Nursing and Allied Health Literature, The Allied and Complementary Medicine Database, 
National Research Register and In Process Medline. All the relevant prospective studies were 
identified by the PubMed searches and therefore a change in the protocol was made and only 
PubMed was used for the updated searches from January 2006 up to 31st August 2011. We 
followed a prespecified protocol, which includes details of the search terms used, for the 
review (http://www.dietandcancerreport.org/ downloads/SLR_Manual.pdf). We also searched 
the reference lists of all the studies that were included in the analysis. We followed standard 
criteria for conducting and reporting meta-analyses [29].  
 
Study selection 
We included prospective cohort, case–cohort and nested case–control studies investigating 
the association between dietary fiber intake and breast cancer incidence. Relative risk (RR) 
estimates (such as hazard ratio or risk ratio) and 95% confidence intervals (CIs) had to be 
available in the publication. For the dose–response analysis, a quantitative measure of intake 
and the total number of cases and person-years or participants had to be available in the 
publication. Twenty-six potentially eligible full text publications were identified [11–28, 30–
37]. Five duplicate publications were excluded [30–33, 36], three publications on adolescent 
dietary fiber intake were excluded [34, 35, 37], and one publication was excluded because the 
continuous result provided per standard deviation increase in intake was not quantified [19]. 
Data from one of the publications were only included in the subgroup analysis of high versus 
low fiber intake among postmenopausal women [21], because a larger overlapping 
publication was used for the main analysis, but did not report results separately for 
postmenopausal women [23]. One additional publication was excluded from the dose–
response analysis because the comparison was provided only for the highest versus the lowest 
intake [25]. In total, 17 publications were included in the high versus low analyses [11–18, 
20–28] and 15 of these were included in the dose–response analyses (Figure 1, Table S1, 
available at Annals of Oncology online) [11–18, 20, 22–24, 26–28].  
 
Data extraction 
The following data were extracted from each study: first author’s last name, publication year, 
country where the study was conducted, study name, followup period, sample size, 
menopausal status, age, number of cases, dietary assessment method (type, number of items 
and whether it was validated), exposure, quantity of intake, RRs and 95% CIs and variables 
adjusted for in the analysis. We did not assess study quality using a quality score but 
investigated whether study characteristics such as duration of follow-up, number of cases, 
menopausal status and adjustment for confounders, which are indicators of study quality, 
influenced the results in subgroup analyses.  
 
Statistical methods 
Random effects models were used to calculate summary RRs and 95% CIs for the highest 
versus the lowest level of fiber intake and for the dose– response analysis [38]. The average 
of the natural logarithm of the RRs was estimated and the RR from each study was weighted 
by the inverse of its variance. A two-tailed P < 0.05 was considered statistically significant.  
 
For the dose–response analysis, we used the method by Greenland and Longnecker [39] to 
compute study-specific slopes (linear trends) and 95% CIs from the natural logs of the RRs 
and CIs across categories of fiber intake. The method requires that the distribution of cases 
and person-years or noncases and the RRs with the variance estimates for at least three 
quantitative exposure categories are known. We estimated the distribution of cases or person-
years in studies that did not report these but reported the total number of cases or person-
years. The median or mean level of fiber intake in each category of intake was assigned to the 
corresponding RR for each study when provided in the paper. For studies that reported fiber 
intake by ranges of intake, we estimated the mean intake in each category by calculating the 
average of the lower and upper bound. When the highest or lowest category was open-ended, 
we assumed the open-ended interval length to be the same as the adjacent interval. In two 
studies [12, 24] where the upper bound of the highest category was extreme and may have led 
to exaggerated ranges of intake, we also used the width of the adjacent interval to calculate 
the upper bound and midpoint. The dose–response results are presented for a 10 g/day 
increment. A potential nonlinear dose–response relationship between fiber intakes and breast 
cancer was examined using fractional polynomial models [40]. We determined the best fitting 
second order fractional polynomial regression model, defined as the one with the lowest 
deviance. A likelihood ratio test was used to assess the difference between the nonlinear and 
linear models to test for nonlinearity [41]. Heterogeneity between studies was assessed using 
Q and I
2
 statistics [42].  
 
Potential sources of heterogeneity were investigated in subgroup and meta-regression 
analyses. We assessed small-study effects, such as publication bias, using a funnel plot and 
Egger’s test [43] and Begg’s test [44] with results considered to indicate potential small-study 
bias when P < 0.10. We also conducted sensitivity analyses excluding one study at a time to 
check whether the result was driven by a very large study or a study with an extreme result. 
Stata version 10.1 software (StataCorp, College Station, TX) was used for the statistical 
analyses.  
 
 
Results 
 
Sixteen prospective studies (17 publications) [11–18, 20–28] were included in the analysis of 
dietary fiber intake and breast cancer risk (Figure 1, Table S1, available at Annals of 
Oncology online). Six of the studies were from Europe, nine from America and one from 
Asia (Table S1, available at Annals of Oncology online). The range of intake varied from 8.6 
to 21.5 g/day in the various studies and the mean range was 14.7, 14.0 and 8.6 among 
American, European and Asian studies (results not shown). The highest level of intake varied 
from 16.3 to 35.2 g/day (Table S1, available at Annals of Oncology online) and the mean 
intake in the highest category was 25.7, 29.9 and 16.3 g/day in the American, European and 
Asian studies (results not shown). 
 
Dietary fiber 
High versus low analysis.  
Sixteen cohort studies [11–18, 20, 22–28] investigated the association between high versus 
low dietary fiber intake and breast cancer risk and included 26 523 cases among 999 271 
participants. The summary RR for high versus low intake was 0.93 (95% CI 0.89–0.98), with 
no evidence of heterogeneity, I
2
 = 0% and Pheterogeneity = 0.89 
(supplemental Figure S1, available at Annals of Oncology online). The summary RR ranged 
from 0.92 (95% CI 0.87–0.97) when the Nurses’ Health Study was excluded to 0.95 (95% CI 
0.89–1.00) when the NIH-AARP Diet and Health Study was excluded. There was no 
evidence of publication bias with Egger’s test, P = 0.89, or with Begg’s test, P = 0.56. 
 
Dose–response analysis.  
Fifteen cohort studies [11–18, 20, 22–24, 26–28] were included in the dose–response 
analysis. The summary RR per 10 g/day was 0.95 (95% CI 0.91–0.98), with no evidence of 
heterogeneity, I
2
 = 0% and Pheterogeneity = 0.82 (Figure 2A). The test for nonlinearity was 
not statistically significant, Pnonlinearity = 0.11 (Figure 2B). 
 
Fruit fiber 
High versus low analysis.  
Six cohort studies [14, 17, 18, 20, 22, 28] were included in the high versus low analysis fruit 
fiber intake and breast cancer risk, including 14 694 cases among 
502 082 participants. The summary RR for high versus low intake was 0.95 (95% CI 0.86–
1.06), with moderate heterogeneity, I
2
 = 46% and Pheterogeneity = 0.10 (supplemental Figure 
S2A, available at Annals of Oncology online). The summary RR ranged from 0.92 (95% CI 
0.83–1.03) when the Canadian National Breast Screening Study was excluded to 0.97 
(95% CI 0.90–1.05) when the Swedish Mammography Cohort Study was excluded. There 
was no evidence of publication bias with Egger’s test, P = 0.91, or Begg’s test, P = 1.00. 
 
Dose–response analysis.  
Six cohort studies were included in the dose–response analysis [14, 17, 18, 20, 22, 28]. The 
summary RR per 10 g/day was 0.88 (95% CI 0.75–1.03), with moderate heterogeneity, I2 = 
48% and Pheterogeneity = 0.09 (Figure 3A). There was no evidence of a nonlinear association 
between fruit fiber intake and breast cancer risk, Pnonlinearity = 0.21 (results not shown). 
 
Vegetable fiber 
High versus low analysis.  
Six cohort studies [14, 17, 18, 20, 22, 28] were included in the analysis of high versus low 
vegetable fiber intake and breast cancer, including 14 694 cases among 502 082 participants. 
The summary RR was 0.99 (95% CI 0.92–1.07). There was little evidence of heterogeneity, 
I
2
 = 15%, Pheterogeneity = 0.32 (supplemental Figure S2B, available at Annals of Oncology 
online). There was no evidence of small-study bias with Egger’s test, P = 0.96, or with 
Begg’s test, P = 0.71. The summary RR ranged from 0.95 (95% CI 0.87–1.03) when 
excluding the NIH-AARP Diet and Health Study to 1.01 (95% CI: 0.92–1.12) when 
excluding the Nurses’ Health Study. 
 
Dose–response analysis.  
Six cohort studies [14, 17, 18, 20, 22, 28] were included in the dose–response analysis. The 
summary RR per 10 g/day was 0.97 (95% CI 0.55–1.12) with moderate evidence of 
heterogeneity, I
2
 = 39% and Pheterogeneity = 0.14 (Figure 3B). There was no evidence of a 
nonlinear association between vegetable fiber intake and breast cancer risk, 
Pnonlinearity = 0.32 (results not shown). 
 
Cereal fiber 
High versus low analysis.  
Six cohort studies [14, 17, 18, 20, 22, 28] were included in the analysis of high versus low 
cereal fiber intake and breast cancer risk, including 14 694 cases among 502 082 participants. 
The summary RR was 0.96 (95% CI 0.90–1.02) and there was little evidence of 
heterogeneity, I
2
 = 5%, Pheterogeneity = 0.39 (supplemental Figure S2C, available at Annals of 
Oncology online). There was no evidence of small study bias with Egger’s test, P = 0.46, or 
with Begg’s test, P = 0.71. The summary RR ranged from 0.92 (95% CI 0.86–0.98) when 
excluding the Nurses’ Health Study to 0.97 (95% CI 0.90–1.04) when excluding the 
Canadian National Breast Screening Study. 
 
Dose–response analysis.  
Six cohort studies [14, 17, 18, 20, 22, 28] were included in the dose–response analysis. The 
summary RR per 10 g/day was 0.91 (95% CI 0.79–1.04) with moderate evidence of 
heterogeneity, I
2
 = 56%, Pheterogeneity = 0.05 (Figure 3C). There was no evidence of a nonlinear 
association between cereal fiber intake and breast cancer risk, Pnonlinearity = 1.00 (results not 
shown). 
 
Soluble and insoluble fiber 
High versus low analysis.  
Five studies [14, 17, 25, 27, 28] investigated soluble fiber and six studies [14, 17, 24, 25, 27, 
28] investigated insoluble fiber in relation to breast cancer risk. The summary RRs for high 
versus low intake were 0.91 (95% CI 0.84–0.99, I2 = 7%, Pheterogeneity = 0.36) for soluble fiber 
(supplemental Figure S3A, available at Annals of Oncology online) and 0.96 (95% CI 0.88–
1.04, I
2
 = 0%, Pheterogeneity = 0.55) for insoluble fiber (supplemental Figure S3B, available at 
Annals of Oncology online), respectively. 
 
Dose–response analysis.  
In the dose–response analysis, four studies of soluble fiber [14, 17, 27, 28] and five studies of 
insoluble fiber [14, 17, 24, 27, 28] were included. The summary RR was 0.74 (95% CI 0.63–
0.88, I
2
 = 0%, Pheterogeneity = 0.77) (Figure 4A) and 0.96 (95% CI 0.86–1.07, I
2
 = 36%, 
Pheterogeneity = 0.18) (Figure 4B) per 10 g/day, respectively. There was no evidence of a 
nonlinear association between soluble fiber and breast cancer risk, Pnonlinearity = 0.69 (Figure 
4C), but some suggestion of a nonlinear association with insoluble fiber, although the test for 
nonlinearity was not significant, P = 0.07 (Figure 4D).  
 
Subgroup and sensitivity analyses.  
In stratified analyses (Table 1), the association between high versus low fiber intake and 
breast cancer risk was inverse in most strata, although not always statistically significant. In 
meta-regression analyses, there was no evidence of a difference in the results between 
strata defined by menopausal status (Table 1) and estrogen and progesterone receptor status. 
Only three studies could be included in the analysis stratified by hormone receptor status, 
the summary RR for high versus low fiber intake was 0.91 (95% CI 0.79–1.06, I2 = 0%, 
Pheterogeneity = 0.83) for ER+/PR+ tumors, 0.89 (95% CI 0.67–1.19, I
2
 = 0%, Pheterogeneity = 0.37) 
for ER+/PR2 tumors and 0.76 (95% CI 0.52–1.11, I2 = 24%, Pheterogeneity = 0.27) for ER2/PR2 
tumors with no heterogeneity between subgroups (Pheterogeneity = 0.33; results not shown) [22, 
28, 33]. The summary estimates in premenopausal and postmenopausal breast cancers were 
similar. No significant difference emerged when stratified by study characteristics such as 
number of cases, duration of follow-up and geographic location or for adjustment for 
confounding variables (P ≥ 0.08 for all comparisons) (Table 1). When analyzed by food 
source, intakes of fruit, vegetable or cereal fiber were not significantly associated with breast 
cancer risk in subgroup analyses and there was no evidence of heterogeneity in the subgroup 
analyses (supplemental Table S2, available at Annals of Oncology online). 
 
One study reported results using more extreme categorizations of intake (>30 g/day versus 
£10 g/day) in addition to quintile-based analyses [18]. In a sensitivity analysis, using the 
results from the more extreme categorization instead of the quintile-based analysis for that 
study, the summary RR for high versus low intake was 0.92 (95% CI 0.87–0.97, I2 = 0%, 
Pheterogeneity = 0.84). 
 
We conducted additional subgroup analyses for total dietary fiber stratified by the level of 
intake in the highest category and by the range of intake. In the high versus low analysis, the 
summary RR was 0.98 (95% CI 0.90–1.08) for studies where the highest intake was <25 
g/day (mean: 21.8 g/day) and 0.91 (95% CI 0.86–0.97) for studies where the highest intake 
was ≥25 g/day (mean: 29.4 g/day). When stratified by the range of intake, the summary 
RR was 0.96 (95% CI 0.88–1.05) for studies with a range <13 g/day (mean: 11.5 g/day) and 
0.92 (95% CI 0.86–0.98) for studies with a range ≥13 g/day (mean: 15.8 g/day) (results not 
shown). Furthermore, to assess whether exclusion of one study [25] from the dose–response 
analysis of total dietary fiber might have influenced the results, we repeated the high versus 
low intake analysis restricted to the studies included in the dose–response analysis. The 
summary RRs for dietary fiber intake and breast cancer risk were 0.92 (95% CI 0.88–0.98), 
almost identical to the result from the high versus low analysis including all studies. 
 
 
Discussion 
 
We found an inverse association between dietary fiber intake and breast cancer risk in this 
meta-analysis based on prospective studies; however, the association appeared to be most 
pronounced in studies with high levels (≥25 versus <25 g/day) or large ranges (≥13 versus 
<13 g/day) of fiber intake. We found that intake of soluble fiber but not insoluble fiber, fruit 
fiber, vegetable fiber or cereal fiber was inversely associated with breast cancer risk. Fewer 
studies were included in these analyses and may have limited our power to detect 
associations.  
 
Our results of a lower breast cancer risk with high fiber intake are consistent with a meta-
analysis of 12 case–control studies, which found an inverse association (summary OR = 0.85) 
between dietary fiber intake and breast cancer risk [10]. However, our results that are based 
on prospective studies are less prone to recall and selection biases. Such biases can make it 
difficult to draw firm conclusions; thus, these results confirm this hypothesis with more 
reliable evidence than available previously.  
 
Our meta-analysis may have several limitations that must be taken into consideration. The 
inverse association between fiber intake and breast cancer risk could be due to unmeasured or 
residual confounding. Higher intake of dietary fiber is often associated with other lifestyle 
factors including higher levels of physical activity, lower prevalence of overweight/obesity 
and lower intakes of alcohol and dietary fat [28]. However, many of the studies included in 
this meta-analysis adjusted for these and other potential confounders. Furthermore, in 
subgroup and meta-regression analyses, we found no difference in the results when stratified 
by whether they adjusted for confounding factors or not. Only few studies reported results 
stratified by hormone receptor status and this may have limited our statistical power to detect 
significant associations in these subgroup analyses.  
 
Measurement errors in the assessment of dietary intake are known to bias effect estimates. 
However, because of the prospective design of the included studies, such measurement errors 
are most likely to have resulted in bias toward the null and attenuated associations. Only one 
of the studies compared the results with and without correction for measurement error [28]. 
The age-adjusted RR for a 10 g/day increase in fiber intake was 0.94 (95% CI 0.90–0.98) and 
after correction for measurement error the RR became 0.89 (95% CI 0.82–0.97), suggesting 
important attenuation of the risk estimates by measurement errors. The level or range of 
intake may have been too low or narrow to detect associations in some of the studies included 
in this meta-analysis and this may have led to an underestimation of the association in the 
high versus low and linear dose–response analyses; thus, examining the shape of the dose–
response relationship may be important to clarify inconsistencies in the results between 
studies. Consistent with this are the results from the subgroup analyses stratified by the level 
and range of intake, which showed that the inverse association was only observed in the 
subgroup of studies with a level of intake of ≥25 g/day in the highest category or a range of 
≥13 g/day. In addition, one study reported no association between fiber intake in quintile-
based analyses (RR = 0.98, 95% CI 0.87–1.11) and in decile-based analyses, but when 
absolute cut points were used for the analysis, a suggestive inverse association was observed 
for intakes above 30 g/day compared with intakes of £10 g/day (RR = 0.68, 95% CI 0.43–
1.06); however, only 0.7% of the cohort had an intake above 30 g/day [18]. We found no 
statistical evidence of small-study bias, such as publication bias, in this meta-analysis and 
there was also no asymmetry in the funnel plots when inspected visually.  
 
Several potential mechanisms may explain an inverse association between fiber intake and 
breast cancer risk. Experimental studies found that a modified citrus pectin (a soluble fiber) 
reduced mammary tumor growth, angiogenesis and metastasis in mice [45] and that a high 
dietary fiber diet reduced mammary tumor incidence in rat models [46, 47]. One study 
reported a lower mammary tumor incidence in rats fed equal amounts of soluble and 
insoluble fiber compared with rats fed only insoluble fiber [48]. Epidemiological studies [49–
52] and intervention studies [9, 53] have shown reductions in circulating estrogen and 
androstenedione levels with a high fiber intake, although not all studies found an association 
[54, 55] and the results by type of fiber type are inconsistent [49, 52, 53]. Conjugated 
estrogens in the liver are excreted into the bile and reabsorbed in the intestine. Fiber may bind 
estrogens in the colon during the enterohepatic circulation and increase the fecal excretion of 
estrogens. In addition, dietary fiber may reduce intestinal b-glucuronidase activity, which is 
necessary for hydrolysis of conjugated estrogens before absorption, thus, resulting in less 
reabsorption of estrogens [48]. Soluble fiber may delay gastric emptying and increase small 
intestine transit time, thereby slowing glucose absorption, reducing insulin secretion and 
hyperinsulinemia [56, 57]. High intake of dietary fiber may also reduce the risk of 
overweight/obesity [58], which is an established risk factor for postmenopausal breast cancer 
[6]; however, the association was also present in studies that adjusted for body mass index or 
weight, suggesting an association independent of overweight/obesity.  
 
Our meta-analysis also has several strengths. Because we based our analyses on prospective 
studies, we have minimized the possibility that our findings may be due to recall and selection 
bias. The studies included a large number of cases and participants and with a total of ~500 
000 to 1 000 000 participants and 15 000–26 000 cases, we had sufficient statistical power to 
detect moderate associations. There was little evidence of heterogeneity in the analyses and 
we did not find evidence that the results differed when stratified by numerous study 
characteristics.  
 To our knowledge, this is the first meta-analysis to explore a potential nonlinear association 
of fiber intake with breast cancer risk. Although we did not find evidence of nonlinearity with 
the statistical tests used, significant inverse associations were observed only among studies 
with a large range or high level of intake. Studies in populations with a low intake and small 
range of intake were less able to detect associations than the studies with higher variability 
and intake. Achieving such a level of fiber intake may be a challenge in many populations, 
nevertheless, considering the few dietary risk factors that have been established for breast 
cancer and the relatively low or moderate fiber intake in many populations [17, 18, 24, 26], 
diets with high intake of plant-based foods rich in fiber could have an impact in the 
prevention of breast cancer. In addition, such diets may reduce the risk of cardiovascular 
disease [59], obesity [58], type 2 diabetes [60], colorectal cancer [61] and other chronic 
diseases [62].  
 
In conclusion, our results suggest that diets rich in fiber are associated with reduced breast 
cancer risk. Further studies of specific types of fiber and breast cancer risk stratified by 
hormone receptor status could clarify the biological mechanism(s) behind this finding.   
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Table 1. Subgroup analyses of dietary fiber intake and breast cancer, high versus low intake 
 n RR (95% CI) I
2
 (%) Ph
1 
All studies 15 0.93 (0.88-0.98) 0 0.85 
Duration of follow-up     
    <10 yrs follow-up 13 0.93 (0.87-0.99) 0  0.84 
    ≥10 yrs follow-up 2 0.94 (0.82-1.09) 18.8 0.27 
Menopausal status     
    Premenopausal 4 0.90 (0.73-1.10) 23.2 0.27 
    Pre- & postmenopausal 2 0.91 (0.79-1.05) 0 0.89 
    Postmenopausal 12 0.93 (0.87-1.00) 0 0.60 
Geographic location      
    Europe 6 0.90 (0.81-1.00) 0 0.76 
    America 8 0.93 (0.87-1.00) 0 0.75 
    Asia 1 1.09 (0.84-1.41)   
Number of cases     
    Cases <500 3 1.00 (0.79-1.27) 0 0.68 
    Cases 500-<1500 8 0.91 (0.83-1.01) 0 0.67 
    Cases ≥1500 4 0.93 (0.87-1.00) 0 0.48 
Adjustment for confounders 
Hormone therapy Yes  8 0.93 (0.87-0.99) 0 0.60 
No  7 0.95 (0.85-1.08) 0 0.81 
OC use Yes  5 0.92 (0.84-1.01) 0 0.80 
No  10 0.94 (0.88-1.01) 0 0.64 
Age at menarche Yes  8 0.95 (0.88-1.03) 0 0.81 
No  7 0.91 (0.84-0.98) 0 0.65 
Age at menopause Yes  8 0.93 (0.87-0.99) 0 0.57 
No 7 0.94 (0.85-1.04) 0 0.83 
Age at 1
st
 birth Yes  10 0.94 (0.88-1.00) 0 0.69 
No 5 0.91 (0.80-1.03) 0 0.78 
Parity  Yes  11 0.91 (0.86-0.97) 0 0.91 
No 4 1.08 (0.92-1.26) 0 0.95 
Education  Yes  8 0.92 (0.86-0.98) 0 0.59 
No  7 0.96 (0.87-1.05) 0 0.86 
Alcohol  Yes 11 0.92 (0.87-0.98) 0 0.81 
No  4 1.00 (0.85-1.17) 0 0.62 
Smoking  
 
Yes  4 0.88 (0.81-0.96) 0 0.91 
No  11 0.97 (0.90-1.04) 0 0.86 
Body mass index, 
weight, WHR 
Yes  12 0.93 (0.88-0.99) 0 0.77 
No  3 0.93 (0.73-1.20) 0 0.52 
Physical activity  
 
Yes  8 0.93 (0.86-1.00) 0 0.58 
No  7 0.94 (0.86-1.03) 0 0.81 
Fruit, vegetables Yes 2 0.86 (0.78-0.96) 0 0.85 
No  13 0.96 (0.90-1.02) 0 0.92 
Fat Yes 5 0.89 (0.82-0.97) 0 0.63 
No  10 0.97 (0.90-1.04) 0 0.89 
Energy intake Yes 14 0.93 (0.88-0.98) 0 0.84 
No  1 1.07 (0.76-1.51)   
 
n denotes the number of studies. 
1
 P for heterogeneity within each subgroup, 
2
 P for 
heterogeneity between subgroups with meta-regression analysis 
 
  
Figure 1. Flow-chart of study selection. 
 
  
34148 records identified in Pubmed from 1966 to 30 
April 2011 and via handsearching  
 
2160 full-text articles retrieved and assessed for 
inclusion 
1532 publications included in the WCRF/AICR 
systematic literature review 
15 publications from 15 prospective studies were 
included in the meta-analysis 
    
 
      
31988 records excluded on the basis of title and 
abstract 
628 articles excluded for not fulfilling the 
WCRF/AICR inclusion criteria 
1507 publications reported on topics other than 
dietary fiber intake and breast cancer, or of study 
type other than a cohort study 
25 potentially relevant publications reporting on 
dietary fiber intake and breast cancer risk 10 publications were excluded 
       6 duplicate publications 
       3 publications on adolescent dietary fiber 
       1 publication was excluded because the  
          continuous result was not quantified 
 
Figure 2. Dietary fiber and breast cancer, linear and nonlinear dose response. CI, confidence 
interval. 
 
  
Figure 3. Fiber types and breast cancer, dose–response analysis per 10 g/day. CI, confidence 
interval. 
  
Figure 4. Soluble and insoluble fiber and breast cancer. CI, confidence interval. 
 
 
